• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Consumer Discretionary

Jim Cramer: Valuations Now Have No Relation to Common Sense

Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.
By JIM CRAMER Sep 17, 2018 | 06:41 AM EDT
Stocks quotes in this article: V, GPN, INTU, SQ, JPM, C, WFC, GS, SPGI, FISV, AXP, CI, ANTH, HUM, UNH, CNC, ZBH, TMO, MDT, ABT, PKI, ILMN, BDX, BSX, ISRG, K, HSY, CL, HRL, MCK, CLX, MA

In this particular market, you have to wonder sometimes if anyone even cares about how expensive certain stocks are. At the same time, you have to be concerned that there seems to be no level that's cheap enough to attract buyers to certain names.

Let me give you some classic examples. I swear it doesn't matter what's happening right now at Mastercard (MA)  , Visa (V) , Global Payments (GPN) , Intuit (INTU) or Square (SQ) , those stocks are going to go up on good days and barely get dented on bad ones. They have jumped whole multiple turnstiles on nothing, not a word. On crickets!

At the same time, there is really nothing that JP Morgan (JPM) or Citigroup (C) or Wells Fargo (WFC) -- or even the regional banks -- can say that would entice people to buy them. I look at Goldman Sachs (GS) every day and marvel at how little people are willing to pay for its shares because it is somehow viewed as a keeper of a moribund industry. But S&P Global (SPGI) or Fiserv (FISV) , there really isn't a limit to what's too expensive. It is value trap vs. ever-higher value, regardless of what's been said or done.

Periodically you get a chance to buy these stocks, like when American Express (AXP) reported a number where revenue growth allegedly slowed and spending ramped. That knocked the stock down from $102 to $99 but you literally had to ignore every single negative word that was said about the stock -- and there were plenty -- and you just had to hold your nose and buy it.

Same thing goes for anything involving health care insurance. These stocks and you know which ones I am talking about -- Centene (CNC) , UnitedHealth (UNH) , Humana (HUM) , Anthem (ANTH) , Cigna (CI) -- it doesn't matter, does it? Whatever they say is well received. Whatever they do is A-Okay.

It doesn't matter if there are quarrels with states or with employees or with the Federal government: Everything negative is just a speed bump to a higher place.

  • Assessing the Market a Decade After Lehman Brothers' Collapse
  • 3 Big-Name Stocks You Should Consider Shorting This Week

Don't you wish you owned nothing but medical device and equipment stocks? Can you imagine owning nothing but Boston Scientific (BSX) , Becton Dickenson (BDX) , Illumina (ILMN) , PerkinElmer (PKI) , Abbott Labs (ABT) , Medtronic (MDT) , Thermo Fisher Scientific (TMO) , Zimmer Biomet (ZBH) and the like? Would you ever be wrong? Intuitive Surgical (ISRG) ? Canonized. Sainted.

And yet, when you look at the price-to-earnings multiples of these, you struggle to justify owning any of them. In the old days, they would be per se shorts no matter what. But there is such a scarcity of stock to buy -- especially of the winners -- and such overwhelming ETF money coming in, that it pushes up these winners endlessly. And the same mutual and hedge funds that are winning with them are getting more money in BECAUSE of them, so that it never seems to end.

I could go on and on about particular industries: Anything that helps small business, companies that are in cyber security, any cloud king or prince. The valuations don't matter.

But then you have the oil and gas stocks and, literally, they are just toxic. And when you try to buy them, you are annihilated. It doesn't seem to matter how low they go; They can go to where oil was at $40 going to $26, and, despite oil being strong at $69, it means nothing.

Periodically, you do get some variation within a group. For example, most of the housing-related stocks are terrible, except for Sherwin-Williams SHW, which I think is because it is reaping the benefits of the bold action to buy Valspar, its competitor. Most consumer packaged goods companies look weak, unless they are perceived to be acquisition targets -- Hormel Foods (HRL) , Colgate-Palmolive (CL) , Hershey (HSY) and Kellogg (K) come to mind -- or they are thought of as acquirers: Clorox (CLX) and McCormick (MCK) , the spice company, come under that rubric.

I probably have a dozen more outliers.

What's so frustrating, what's so maddening about this market right now, though, is that valuation makes no difference whatsoever in anyone's thinking. Anyone. You get these downgrades by analysts on valuation and you just roll your eyes because, you see -- and this is really the rub -- the buyers do not care. They aren't going to stop here. They get new money in, they look at their stocks, they think their stocks are cheap and they buy more of them.

It's an insanely non-rigorous virtuous circle. You want to boil down the current investment thesis? It goes like this: I buy them because they go higher and they go higher because I buy them.

Could there be a more stupid or a more profitable investment strategy at this moment -- and perhaps until the end of the year? I don't know. I can't think of one.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Action Alerts PLUS, which Cramer co-manages as a charitable trust, is long C, JPM, GS, ABT and UNH.

TAGS: ETFs | Funds | Investing | Stocks | Consumer | Financial Services | Healthcare | Consumer Staples | Consumer Discretionary | U.S. Equity

More from Consumer Discretionary

Let's See How Ulta Looks in the Mirror After Earnings

Bruce Kamich
May 26, 2023 2:30 PM EDT

The shares are down sharply after the retailer reported its latest earnings.

As e.l.f. Beauty Stock Surges, Here's My New Strategy

Bruce Kamich
May 25, 2023 1:34 PM EDT

ELF reported an earnings beat as the business seems very resilient.

Bearish Bets: 3 Stocks You Should Think About Shorting This Week

Bob Lang
May 21, 2023 10:30 AM EDT

These recently downgraded names are displaying both quantitative and technical deterioration.

Match Shares Are Searching for a Strong Connection With Buyers

Bruce Kamich
May 19, 2023 10:57 AM EDT

The stock has been in a persistent downtrend the past 12 months.

I'm Taking a Swing at Topgolf Callaway From the Rough

Ed Ponsi
May 18, 2023 10:15 AM EDT

The shares of the golf-focused recreation company are approaching a support level from which it has bounced back a few times.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 09:48 AM EDT CHRIS VERSACE

    Latest AAP Podcast With Portillo's CEO!

    Listen in as we talk with a rising star in the Chi...
  • 03:25 PM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Don't Just Sit There and 'Hope' for Your Stocks, M...
  • 07:32 AM EDT BOB LANG

    Webinar Thursday After the Close: Option Spread Trading

    Thursday, my good friend and colleague Sam DeMarco...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login